Suppr超能文献

LRRK2 基因敲除可使 HEK-293 细胞抵抗鱼藤酮诱导的氧化应激、线粒体损伤和细胞凋亡。

LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis.

机构信息

Neuroscience Research Group, Institute of Medical Research, Faculty of Medicine, University of Antioquia, University Research Headquarters, Calle 62#52-59, Building 1, Laboratory 411/412, Medellin 050010, Colombia.

Genomic Medicine Department, Centre for Genomics and Oncological Research (GENYO), Pfizer-University of Granada-Andalusian Regional Government, Parque Tecnólogico Ciencias de la Salud, Av. de la Ilustración 114, 18016 Granada, Spain.

出版信息

Int J Mol Sci. 2023 Jun 22;24(13):10474. doi: 10.3390/ijms241310474.

Abstract

Leucine-rich repeat kinase 2 (LRRK2) has been linked to dopaminergic neuronal vulnerability to oxidative stress (OS), mitochondrial impairment, and increased cell death in idiopathic and familial Parkinson's disease (PD). However, how exactly this kinase participates in the OS-mitochondria-apoptosis connection is still unknown. We used clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 LRRK2 knockout (KO) in the human embryonic kidney cell line 293 (HEK-293) to evaluate the cellular response to the mitochondrial inhibitor complex I rotenone (ROT), a well-known OS and cell death inducer. We report successful knockout of the LRRK2 gene in HEK-293 cells using CRISPR editing (ICE, approximately 60%) and flow cytometry (81%) analyses. We found that HEK-293 LRRK2 WT cells exposed to rotenone (ROT, 50 μM) resulted in a significant increase in intracellular reactive oxygen species (ROS, +7400%); oxidized DJ-1-Cys-SO (+52%); phosphorylation of LRRK2 (+70%) and c-JUN (+171%); enhanced expression of tumor protein (TP53, +2000%), p53 upregulated modulator of apoptosis (PUMA, +1950%), and Parkin (PRKN, +22%); activation of caspase 3 (CASP3, +8000%), DNA fragmentation (+35%) and decreased mitochondrial membrane potential (ΔΨm, -58%) and PTEN induced putative kinase 1 (PINK1, -49%) when compared to untreated cells. The translocation of the cytoplasmic fission protein dynamin-related Protein 1 (DRP1) to mitochondria was also observed by colocalization with translocase of the outer membrane 20 (TOM20). Outstandingly, HEK-293 LRRK2 KO cells treated with ROT showed unaltered OS and apoptosis markers. We conclude that loss of LRRK2 causes HEK-293 to be resistant to ROT-induced OS, mitochondrial damage, and apoptosis in vitro. Our data support the hypothesis that LRRK2 acts as a proapoptotic kinase by regulating mitochondrial proteins (e.g., PRKN, PINK1, DRP1, and PUMA), transcription factors (e.g., c-JUN and TP53), and CASP3 in cells under stress conditions. Taken together, these observations suggest that LRRK2 is an important kinase in the pathogenesis of PD.

摘要

富含亮氨酸重复激酶 2(LRRK2)与多巴胺能神经元对氧化应激(OS)、线粒体损伤和特发性和家族性帕金森病(PD)中细胞死亡的易感性有关。然而,这种激酶究竟如何参与 OS-线粒体-凋亡连接仍然未知。我们使用人胚肾细胞系 293(HEK-293)中的成簇规律间隔短回文重复(CRISPR)/Cas9 LRRK2 敲除(KO)来评估线粒体抑制剂复合物 I 鱼藤酮(ROT)对细胞的反应,鱼藤酮是一种众所周知的 OS 和细胞死亡诱导剂。我们报告了使用 CRISPR 编辑(ICE,约 60%)和流式细胞术(81%)分析成功敲除 HEK-293 细胞中的 LRRK2 基因。我们发现,暴露于鱼藤酮(ROT,50 μM)的 HEK-293 LRRK2 WT 细胞导致细胞内活性氧(ROS,+7400%)显著增加;氧化 DJ-1-Cys-SO(+52%);LRRK2 磷酸化(+70%)和 c-JUN(+171%);肿瘤蛋白(TP53,+2000%)、p53 上调凋亡调节剂(PUMA,+1950%)和 Parkin(PRKN,+22%)的表达增强;半胱天冬酶 3(CASP3,+8000%)的激活、DNA 片段化(+35%)和线粒体膜电位(ΔΨm,-58%)以及 PTEN 诱导的潜在激酶 1(PINK1,-49%)降低与未处理细胞相比。细胞质分裂蛋白 dynamin 相关蛋白 1(DRP1)与外膜转运蛋白 20(TOM20)的共定位也观察到了向线粒体的易位。值得注意的是,用 ROT 处理的 HEK-293 LRRK2 KO 细胞的 OS 和凋亡标志物未改变。我们得出结论,LRRK2 的缺失导致 HEK-293 在体外对 ROT 诱导的 OS、线粒体损伤和凋亡具有抗性。我们的数据支持这样的假设,即 LRRK2 通过调节应激条件下的线粒体蛋白(例如 PRKN、PINK1、DRP1 和 PUMA)、转录因子(例如 c-JUN 和 TP53)和 CASP3 作为促凋亡激酶发挥作用。总之,这些观察结果表明 LRRK2 是 PD 发病机制中的一个重要激酶。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验